Expression of E-cadherin and alpha- and beta-catenin mRNAs in ovarian cancers

被引:26
|
作者
Fujimoto, J
Ichigo, S
Hirose, R
Sakaguchi, H
Tamaya, T
机构
[1] Department of Obstetrics, Gifu University School of Medicine, Gifu City 500
关键词
E-cadherin; alpha- and beta-catenin; ovarian cancer;
D O I
10.1016/S0304-3835(97)04735-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
To know the biological role of the adherens junction, mainly consisting of E-cadherin and alpha- and beta-catenins, associated with invasion and metastasis of ovarian cancers, we studied the expressions of E-cadherin and alpha- and beta-catenin mRNAs in the cancers in comparison with those in normal counterparts. The integral expression of E-cadherin and alpha- and, beta-catenin mRNAs was suppressed in the metastatic lesions of advanced ovarian cancers, while it was not in the primary tumors. Therefore, the suppressed expression of main adhesion molecules in the adherens junction might contribute to adherens junctional dysfunction, which might lead to the acquirement of invasiveness and metastatic potential by advanced ovarian cancers as one of the rate-limiting steps. (C) 1997 Elsevier Science Ireland Ltd.
引用
收藏
页码:207 / 212
页数:6
相关论文
共 50 条
  • [41] Expression of E-cadherin, α-catenin, and β-catenin in tubulolobular carcinoma of the breast
    Hajime Kuroda
    Jun-ichi Tamaru
    Ikuya Takeuchi
    Kiyoshi Ohnisi
    Goi Sakamoto
    Akiko Adachi
    Kou Kaneko
    Shinji Itoyama
    Virchows Archiv, 2006, 448 : 500 - 505
  • [42] Expression of E-cadherin, α-catenin, and β-catenin in tubulolobular carcinoma of the breast
    Kuroda, H
    Tamaru, J
    Takeuchi, I
    Ohnisi, K
    Sakamoto, G
    Adachi, A
    Kaneko, K
    Itoyama, S
    VIRCHOWS ARCHIV, 2006, 448 (04) : 500 - 505
  • [43] E-Cadherin and Alpha-Catenin Expression in Normal, Hyperplastic and Neoplastic Endometrium
    Carico, Elisabetta
    Atlante, Marco
    Giarnieri, Enrico
    Raffa, Salvatore
    Bucci, Barbara
    Giovagnoli, Maria Rosaria
    Vecchione, Aldo
    ANTICANCER RESEARCH, 2010, 30 (12) : 4993 - 4997
  • [44] Expression and Localization of E-Cadherin in Epithelial Ovarian Cancer
    Koensgen, Dominique
    Freitag, Cornelia
    Klaman, Irina
    Dahl, Edgar
    Mustea, Alexander
    Chekerov, Radoslav
    Braicu, Ioana
    Lichtenegger, Werner
    Sehouli, Jalid
    ANTICANCER RESEARCH, 2010, 30 (07) : 2525 - 2530
  • [45] Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: Relationships with tumor grade, clinicopathologic parameters, and patients' survival
    Endo, K
    Ueda, T
    Ueyama, J
    Ohta, T
    Terada, T
    HUMAN PATHOLOGY, 2000, 31 (05) : 558 - 565
  • [46] Beta-catenin and E-cadherin tissue "content" as prognostic markers in left-side colorectal cancer
    Martinez, Natalia Peres
    Kanno, Danilo Toshio
    Pereira, Jose Aires
    Cardinalli, Izilda Aparecida
    Priolli, Denise Goncalves
    CANCER BIOMARKERS, 2010, 8 (03) : 129 - 135
  • [47] Immunohistochemical expression of E-cadherin and β-catenin in the normal and malignant human endometrium:: An inverse correlation between E-cadherin and nuclear β-catenin expression
    Shih, HC
    Shiozawa, T
    Miyamoto, T
    Kashima, H
    Feng, YZ
    Kurai, M
    Konishi, I
    ANTICANCER RESEARCH, 2004, 24 (06) : 3843 - 3850
  • [48] E-cadherin and β-catenin expression in sebaceous eyelid adenocarcinomas
    Liang Li
    Zhe Zhang
    Bin Li
    Fei Gao
    Liaoqing Li
    Jost B. Jonas
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2011, 249 : 1867 - 1873
  • [49] The reduced expression of E-cadherin, α-catenin and γ-catenin but not β-catenin in human lung cancer
    Toyoyama, H
    Nuruki, K
    Ogawa, H
    Yanagi, M
    Matsumoto, H
    Nishijima, H
    Shimotakahara, T
    Aikou, T
    Ozawa, M
    ONCOLOGY REPORTS, 1999, 6 (01) : 81 - 85
  • [50] E-cadherin and β-catenin expression in breast medullary carcinomas
    Charpin, C
    Bonnier, P
    Garcia, S
    Andrac, L
    Crebassa, B
    Dorel, M
    Lavaut, MN
    Allasia, C
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1999, 15 (02) : 285 - 292